Tocilizumab

Brand name: Actemra

Rank #159 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$99.5M

Total Cost

Share:

24,891

Total Claims

$99.5M

Total Cost

1,188

Prescribers

$3,998

Cost per Claim

235

Beneficiaries

26,222

30-Day Fills

$84K

Avg Cost/Provider

21

Avg Claims/Provider

Share of Medicare Part D Spending

0.04%

of total Medicare Part D spending

$99.5M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $99.5M total

🔎 Data Overview

💰

At $3,998 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $423,418 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Tocilizumab

#ProviderSpecialtyLocationClaimsCost
1Gerald HoRheumatologyLa Palma, CA210$615K
2Celine WardInternal MedicineCharleston, SC87$500K
3Mark TanRheumatologySmithtown, NY107$478K
4Hing-Sheung FungInternal MedicineWaco, TX122$465K
5Mark MatzaRheumatologyBoston, MA101$454K
6Shubhasree BanerjeeRheumatologyPhiladelphia, PA94$441K
7Alexandra Villa ForteRheumatologyCleveland, OH88$437K
8Guillermo ValenzuelaRheumatologyPlantation, FL145$411K
9Ricardo Garcia AlemanyRheumatologyHialeah, FL89$381K
10Maria Thomas-JohnRheumatologyDayton, OH50$374K
11Jeanne GosselinRheumatologyBurlington, VT92$372K
12Brendan ThomsRheumatologyBurlington, VT88$336K
13Cosmin DascaluRheumatologyGlen Oaks, NY89$320K
14William MonacoRheumatologyLebanon, NH58$317K
15Lauren WireNurse PractitionerHilliard, OH64$311K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
156Quetiapine Fumarate (Quetiapine Fumarate)$100.9M3,820,737
157Ubrogepant (Ubrelvy)$100.6M75,781
158Darunavir/Cobicistat (Prezcobix)$99.7M38,374
159Tocilizumab (Actemra)$99.5M24,891
160Omalizumab (Xolair)$98.9M30,451
161Brimonidine Tartrate (Alphagan P)$98.8M988,570
162Dexlansoprazole (Dexlansoprazole Dr)$98.7M275,116

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology